Enko raises overall capital to date to $150 million
Enko has raised additional funding, bringing the company’s overall capital raised to date to $150 million. Enko will use the new funds to advance the company’s...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Enko has raised additional funding, bringing the company’s overall capital raised to date to $150 million. Enko will use the new funds to advance the company’s...
View this email in your browser February 9, 2023 Senator Chris Murphy recently announced Modifi Bio as “Innovator of the Month” for January. Murphy said, “Modifi Bio...
ConnCAT – one of the states leading job training and skill-building organizations – is teaming up with Yale to launch a program to train New Haven...
Connecticut Innovations, the state’s strategic venture capital arm, has launched a new fund committed to investing in early-stage companies, with an emphasis on underrepresented founders. The...
View this email in your browser February 7, 2023 Arvinas Summer Internship, Neuroscience New Haven Summer Internship, Drug Discovery, Artificial Intelligence New Haven Summer Internship,...
BioMed X, a biomedical research institute in Germany, is launching its first U.S. facilityin New Haven. The facility will focus on research in the areas...
View this email in your browser February 2, 2023 Connecticut Innovations (CI) announced that it invested $10 million in early-stage companies and fund of funds during the...
Boehringer Ingelheim and Eli Lilly and Company announced that the FDA has accepted a supplemental New Drug Application for Jardiance® (empagliflozin) tablets. The tablets are being investigated as...
In an effort to practice precision medicine — a medical movement to develop specific treatments for individual patients — scientists created software to quantify and...
BioXcel Therapeutics reports promising top-line data from its Phase 2 trial of BXCL701, the Company’s investigational, oral innate immune activator, in combination with KEYTRUDA® (pembrolizumab) in small...